Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments

Minami Hatono,Hirokuni Ikeda,Yoko Suzuki,Yukiko Kajiwara,Kengo Kawada,Takahiro Tsukioki,Mariko Kochi,Ken Suzawa,Takayuki Iwamoto,Hiromasa Yamamoto,Tadahiko Shien,Masaomi Yamane,Naruto Taira,Hiroyoshi Doihara,Shinichi Toyooka
DOI: https://doi.org/10.1007/s10549-020-05957-z
2020-10-09
Breast Cancer Research and Treatment
Abstract:Epidemiological studies have suggested that intake of soy isoflavones is associated with a reduced risk of development of breast cancer and an improved prognosis in patients with breast cancer. In addition, basic research has demonstrated the antitumor effects of these compounds on breast cancer cell lines. However, the detailed effects of the intake of equol, which is one of the metabolites of the soy isoflavones, are yet to be clarified on the risk of development and recurrence of breast cancer and its interactions with drugs used for treating breast cancer. This study aimed to determine the antitumor effects of equol and investigate the impact of adding equol to therapeutic agents for breast cancer using breast cancer cell lines.
oncology
What problem does this paper attempt to address?